A proteomics approach to the identification of biomarkers for psoriasis utilising keratome biopsy

Journal of Proteomics

Volumn 94, Issue , 2013, Pages 176-185

  Williamson, James C ^a   Scheipers, Peter ^b   Schwämmle, Veit ^a   Zibert, John R ^b   Beck, Hans Christian ^c   Jensen, Ole N ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b LEO PHARMA A S   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Biomarker; Keratome; Plasma; Psoriasis; SRM

Indexed keywords

ARGINASE 1; ASPARTATE AMINOTRANSFERASE ISOENZYME 2; CALGRANULIN A; CARBONYL REDUCTASE; CARBONYL REDUCTASE 1; CARBONYL REDUCTASE 3; CARBOXYPEPTIDASE; CARBOXYPEPTIDASE 2; CELLULAR RETINOIC ACID-BINDING PROTEIN 2; CYSTATIN B; CYTOCHROME C; DESMOGLEIN 1; DESMOGLEIN 3; DIAZEPAM BINDING INHIBITOR; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 5; GASDERMIN A; GLUTAREDOXIN; GLUTATHIONE; PEROXIREDOXIN 5; PROFILIN; PROFILIN I; PROLIFERATION ASSOCIATED PROTEIN 2G4; PSORIASIN; RETINOIC ACID BINDING PROTEIN; SERINE PROTEINASE INHIBITOR; SOLUBLE N ETHYLMALEIMIDE SENSITIVE FACTOR ATTACHMENT PROTEIN; STAT1 PROTEIN; TRANSGELIN; TRANSGELIN 2; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; COMORBIDITY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; EX VIVO STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; ISOTOPE LABELING; KERATOME SKIN BIOPSY; LIQUID CHROMATOGRAPHY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEOMICS; PSORIASIS; PSORIASIS VULGARIS; SKIN BIOPSY; TANDEM MASS SPECTROMETRY;

BIOMARKER; KERATOME; PLASMA; PSORIASIS; SRM;

BIOLOGICAL MARKERS; BIOPSY; HUMANS; MALE; PROTEOME; PROTEOMICS; PSORIASIS; SKIN;

EID: 84885798768     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2013.09.010     Document Type: Article

References (64)

1. Nestle F.O., Kaplan D.H., Barker J. Psoriasis. N Engl J Med 2009, 361:496-509.
2. Dika E., Bardazzi F., Balestri R., Maibach H.I. Environmental factors and psoriasis. Curr Probl Dermatol 2007, 35:118-135.
3. Murphy G., Reich K. In touch with psoriasis: topical treatments and current guidelines. J Eur Acad Dermatol Venereol 2011, 25(Suppl. 4):3-8.
4. Moshkovskii S.A., Sokolova E.E., Brattseva E.V., Karpova M.A., Pyatnitskiy M.A., Kubanova A.A., et al. Proteome and cytokine serum profiling to diagnose a mycosis fungoides. Proteomics Clin Appl 2011, 5:432-439.
5. Pohl D., Andrys C., Borska L., Fiala Z., Hamakova K., Ettler K., et al. CC and CXC chemokines patterns in psoriasis determined by protein array method were influenced by Goeckerman's therapy. Acta Medica (Hradec Kralove) 2009, 52:9-13.
6. Plavina T., Hincapie M., Wakshull E., Subramanyam M., Hancock W.S. Increased plasma concentrations of cytoskeletal and Ca2+-binding proteins and their peptides in psoriasis patients. Clin Chem 2008, 54:1805-1814.
7. Hoskins E.R., Hood B.L., Sun M., Krivak T.C., Edwards R.P., Conrads T.P. Proteomic analysis of ovarian cancer proximal fluids: validation of elevated peroxiredoxin 1 in patient peripheral circulation. PLoS One 2011, 6:e25056.
8. Celis J.E., Gromov P., Cabezon T., Moreira J.M., Ambartsumian N., Sandelin K., et al. Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery. Mol Cell Proteomics 2004, 3:327-344.
9. Zoidakis J., Makridakis M., Zerefos P.G., Bitsika V., Esteban S., Frantzi M., et al. Profilin 1 is a potential biomarker for bladder cancer aggressiveness. Mol Cell Proteomics 2012, 11. [M111 009449].
10. Kroksveen A.C., Opsahl J.A., Aye T.T., Ulvik R.J., Berven F.S. Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics. J Proteomics 2011, 74:371-388.
11. Zibert J.R., Skov L., Thyssen J.P., Jacobsen G.K., Grigorian M. Significance of the S100A4 protein in psoriasis. J Invest Dermatol 2010, 130:150-160.
12. Carlen L.M., Sanchez F., Bergman A.C., Becker S., Hirschberg D., Franzen B., et al. Proteome analysis of skin distinguishes acute guttate from chronic plaque psoriasis. J Invest Dermatol 2005, 124:63-69.
13. Celis J.E., Cruger D., Kiil J., Lauridsen J.B., Ratz G., Basse B., et al. Identification of a group of proteins that are strongly up-regulated in total epidermal keratinocytes from psoriatic skin. FEBS Lett 1990, 262:159-164.
14. Celis J.E., Cruger D., Kiil J., Dejgaard K., Lauridsen J.B., Ratz G.P., et al. A two-dimensional gel protein database of noncultured total normal human epidermal keratinocytes: identification of proteins strongly up-regulated in psoriatic epidermis. Electrophoresis 1990, 11:242-254.
15. Liu S.C., Parsons C.S. Serial cultivation of epidermal keratinocytes from psoriatic plaques. J Invest Dermatol 1983, 81:54-61.
16. Priestley G.C., Lord R. Fibroblast-keratinocyte interactions in psoriasis: failure of psoriatic fibroblasts to stimulate keratinocyte proliferation in vitro. Br J Dermatol 1990, 123:467-472.
17. Pigatto P.D., Pigatto L.B., Bigardi A., Altomare G., Finzi A.F. Factors secreted by untreated psoriatic monocytes enhance neutrophil functions. J Invest Dermatol 1990, 94:372-376.
18. Zhang K., Liu R., Yin G., Li X., Li J., Zhang J. Differential cytokine secretion of cultured bone marrow stromal cells from patients with psoriasis and healthy volunteers. Eur J Dermatol 2010, 20:49-53.
19. Salgo R., Thaci D., Boehncke S., Diehl S., Hofmann M., Boehncke W.H. Microdialysis documents changes in the micromilieu of psoriatic plaques under continuous systemic therapy. Exp Dermatol 2011, 20:130-133.
20. Macdonald N., Cumberbatch M., Singh M., Moggs J.G., Orphanides G., Dearman R.J., et al. Proteomic analysis of suction blister fluid isolated from human skin. Clin Exp Dermatol 2006, 31:445-448.
21. Hsu J.L., Huang S.Y., Chow N.H., Chen S.H. Stable-isotope dimethyl labeling for quantitative proteomics. Anal Chem 2003, 75:6843-6852.
22. Boersema P.J., Raijmakers R., Lemeer S., Mohammed S., Heck A.J. Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics. Nat Protoc 2009, 4:484-494.
23. Gobom J., Nordhoff E., Mirgorodskaya E., Ekman R., Roepstorff P. Sample purification and preparation technique based on nano-scale reversed-phase columns for the sensitive analysis of complex peptide mixtures by matrix-assisted laser desorption/ionization mass spectrometry. J Mass Spectrom 1999, 34:105-116.
24. McNulty D.E., Annan R.S. Hydrophilic interaction chromatography reduces the complexity of the phosphoproteome and improves global phosphopeptide isolation and detection. Mol Cell Proteomics 2008, 7:971-980.
25. Kall L., Canterbury J.D., Weston J., Noble W.S., MacCoss M.J. Semi-supervised learning for peptide identification from shotgun proteomics datasets. Nat Methods 2007, 4:923-925.
26. Taverner T., Karpievitch Y.V., Polpitiya A.D., Brown J.N., Dabney A.R., Anderson G.A., et al. DanteR: an extensible R-based tool for quantitative analysis of -Omics data. Bioinformatics 2012, 28:2404-2406.
27. Smyth G.K., Gentleman R., Carey V., Dudoit S. Limma: linear models for microarray data Bioinformatics and Computational Biology Solutions using R and Bioconductor 2005, 397-420. Springer.
28. Storey J.D. A direct approach to false discovery rates. J R Stat Soc Ser B 2002, 64:479-498.
29. Geiger T., Cox J., Ostasiewicz P., Wisniewski J.R., Mann M. Super-SILAC mix for quantitative proteomics of human tumor tissue. Nat Methods 2010, 7:383-385.
30. MacLean B., Tomazela D.M., Shulman N., Chambers M., Finney G.L., Frewen B., et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 2010, 26:966-968.
31. Farrah T., Deutsch E.W., Omenn G.S., Campbell D.S., Sun Z., Bletz J.A., et al. A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas. Mol Cell Proteomics 2011, 10. [M110 006353].
32. Zulfakar M.H., Alex A., Povazay B., Drexler W., Thomas C.P., Porter R.M., et al. In vivo response of GsdmA3Dfl/+ mice to topically applied anti-psoriatic agents: effects on epidermal thickness, as determined by optical coherence tomography and H&E staining. Exp Dermatol 2011, 20:269-272.
33. Piepkorn M., Predd H., Underwood R., Cook P. Proliferation-differentiation relationships in the expression of heparin-binding epidermal growth factor-related factors and erbB receptors by normal and psoriatic human keratinocytes. Arch Dermatol Res 2003, 295:93-101.
34. Yoo J.Y., Wang X.W., Rishi A.K., Lessor T., Xia X.M., Gustafson T.A., et al. Interaction of the PA2G4 (EBP1) protein with ErbB-3 and regulation of this binding by heregulin. Br J Cancer 2000, 82:683-690.
35. Malatkova P., Ebert B., Wsol V., Maser E. Expression of human carbonyl reductase 3 (CBR3; SDR21C2) is inducible by pro-inflammatory stimuli. Biochem Biophys Res Commun 2012, 420:368-373.
36. Thimmulappa R.K., Mai K.H., Srisuma S., Kensler T.W., Yamamoto M., Biswal S. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res 2002, 62:5196-5203.
37. Ebert B., Kisiela M., Malatkova P., El-Hawari Y., Maser E. Regulation of human carbonyl reductase 3 (CBR3; SDR21C2) expression by Nrf2 in cultured cancer cells. Biochemistry 2010, 49:8499-8511.
38. Schafer M., Farwanah H., Willrodt A.H., Huebner A.J., Sandhoff K., Roop D., et al. Nrf2 links epidermal barrier function with antioxidant defense. EMBO Mol Med 2012, 4:364-379.
39. Reisman S.A., Yeager R.L., Yamamoto M., Klaassen C.D. Increased Nrf2 activation in livers from Keap1-knockdown mice increases expression of cytoprotective genes that detoxify electrophiles more than those that detoxify reactive oxygen species. Toxicol Sci 2009, 108:35-47.
40. Nishinaka T., Miura T., Okumura M., Nakao F., Nakamura H., Terada T. Regulation of aldo-keto reductase AKR1B10 gene expression: involvement of transcription factor Nrf2. Chem Biol Interact 2011, 191:185-191.
41. Ohtsuji M., Katsuoka F., Kobayashi A., Aburatani H., Hayes J.D., Yamamoto M. Nrf1 and Nrf2 play distinct roles in activation of antioxidant response element-dependent genes. J Biol Chem 2008, 283:33554-33562.
42. Miyamoto N., Izumi H., Miyamoto R., Kondo H., Tawara A., Sasaguri Y., et al. Quercetin induces the expression of peroxiredoxins 3 and 5 via the Nrf2/NRF1 transcription pathway. Invest Ophthalmol Vis Sci 2011, 52:1055-1063.
43. Gudjonsson J.E., Ding J., Johnston A., Tejasvi T., Guzman A.M., Nair R.P., et al. Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with in vitro models. J Invest Dermatol 2010, 130:1829-1840.
44. Oestreicher J.L., Walters I.B., Kikuchi T., Gilleaudeau P., Surette J., Schwertschlag U., et al. Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling. Pharmacogenomics J 2001, 1:272-287.
45. Debets R., Timans J.C., Homey B., Zurawski S., Sana T.R., Lo S., et al. Two novel IL-1 family members, IL-1 delta and IL-1 epsilon, function as an antagonist and agonist of NF-kappa B activation through the orphan IL-1 receptor-related protein 2. J Immunol 2001, 167:1440-1446.
46. Suarez-Farinas M., Lowes M.A., Zaba L.C., Krueger J.G. Evaluation of the psoriasis transcriptome across different studies by gene set enrichment analysis (GSEA). PLoS One 2010, 5:e10247.
47. Madsen P., Rasmussen H.H., Leffers H., Honore B., Dejgaard K., Olsen E., et al. Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly up-regulated in psoriatic skin. J Invest Dermatol 1991, 97:701-712.
48. Simon M., Tazi-Ahnini R., Jonca N., Caubet C., Cork M.J., Serre G. Alterations in the desquamation-related proteolytic cleavage of corneodesmosin and other corneodesmosomal proteins in psoriatic lesional epidermis. Br J Dermatol 2008, 159:77-85.
49. Hammar H. NAD and NADP dependent isocitrate dehydrogenase and fumarate hydratase activities in normal human skin and in some maculosquamous diseases of the skin. Arch Dermatol Forsch 1973, 247:295-308.
50. Wu Y.Y., Rees J.L. Variation in epidermal housekeeping gene expression in different pathological states. Acta Derm Venereol 2000, 80:2-3.
51. Ryu J., Park S.G., Park B.C., Choe M., Lee K.S., Cho J.W. Proteomic analysis of psoriatic skin tissue for identification of differentially expressed proteins: up-regulation of GSTP1, SFN and PRDX2 in psoriatic skin. Int J Mol Med 2011, 28:785-792.
52. Anderson K.S., Petersson S., Wong J., Shubbar E., Lokko N.N., Carlstrom M., et al. Elevation of serum epidermal growth factor and interleukin 1 receptor antagonist in active psoriasis vulgaris. Br J Dermatol 2010, 163:1085-1089.
53. Elkayam O., Yaron I., Shirazi I., Yaron M., Caspi D. Serum levels of IL-10, IL-6, IL-1ra, and sIL-2R in patients with psoriatic arthritis. Rheumatol Int 2000, 19:101-105.
54. Kristensen M., Deleuran B., Eedy D.J., Feldmann M., Breathnach S.M., Brennan F.M. Distribution of interleukin 1 receptor antagonist protein (IRAP), interleukin 1 receptor, and interleukin 1 alpha in normal and psoriatic skin. Decreased expression of IRAP in psoriatic lesional epidermis. Br J Dermatol 1992, 127:305-311.
55. Gasior-Chrzan B., Bostad L., Falk E.S. An immunohistochemical study of lysozyme in the skin of psoriatic patients. Acta Derm Venereol 1994, 74:344-346.
56. Mallbris L., O'Brien K.P., Hulthen A., Sandstedt B., Cowland J.B., Borregaard N., et al. Neutrophil gelatinase-associated lipocalin is a marker for dysregulated keratinocyte differentiation in human skin. Exp Dermatol 2002, 11:584-591.
57. Kawahira K. Immunohistochemical staining of proliferating cell nuclear antigen (PCNA) in malignant and nonmalignant skin diseases. Arch Dermatol Res 1999, 291:413-418.
58. Broome A.M., Ryan D., Eckert R.L. S100 protein subcellular localization during epidermal differentiation and psoriasis. J Histochem Cytochem 2003, 51:675-685.
59. Whiteaker J.R., Lin C., Kennedy J., Hou L., Trute M., Sokal I., et al. A targeted proteomics-based pipeline for verification of biomarkers in plasma. Nat Biotechnol 2011, 29:625-634.
60. Tamura M., Tanaka H., Yashiro A., Osajima A., Okazaki M., Kudo H., et al. Expression of profilin, an actin-binding protein, in rat experimental glomerulonephritis and its upregulation by basic fibroblast growth factor in cultured rat mesangial cells. J Am Soc Nephrol 2000, 11:423-433.
61. Caglayan E., Romeo G.R., Kappert K., Odenthal M., Sudkamp M., Body S.C., et al. Profilin-1 is expressed in human atherosclerotic plaques and induces atherogenic effects on vascular smooth muscle cells. PLoS One 2010, 5:e13608.
62. Zou L., Jaramillo M., Whaley D., Wells A., Panchapakesa V., Das T., et al. Profilin-1 is a negative regulator of mammary carcinoma aggressiveness. Br J Cancer 2007, 97:1361-1371.
63. Gronborg M., Kristiansen T.Z., Iwahori A., Chang R., Reddy R., Sato N., et al. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol Cell Proteomics 2006, 5:157-171.
64. Anderson N.L., Anderson N.G., Haines L.R., Hardie D.B., Olafson R.W., Pearson T.W. Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA). J Proteome Res 2004, 3:235-244.